Statistics on branded medicines pricing

Voluntary scheme aggregate net sales and payment information: May 2025

Information on how the 2024 voluntary scheme for branded medicines pricing, access and growth (VPAG) is controlling spend on branded medicines in the NHS.

From:

Department of Health and Social Care

Published

11 July 2025

Documents

Aggregate net sales and payment information: May 2025

HTML

Details

This document sets out the NHS's quarterly aggregate net sales and payment information on pharmaceuticals for May 2025.

The 2024 voluntary scheme for branded medicines pricing, access and growth (VPAG) is an agreement between the Department for Health and Social Care, NHS England and the Association of the British Pharmaceutical Industry that aims to:

• promote better patient outcomes and a healthier population
• support UK economic growth
• contribute to a financially sustainable NHS